Advanced company searchLink opens in new window

AMPHISTA THERAPEUTICS LIMITED

Company number 11119959

Filter by category

Filter by category


Confirmation statement filters

Company Results (links open in a new window)
Date (document was filed at Companies House) Type Description (of the document filed at Companies House) View / Download (PDF file, link opens in new window)
05 Jun 2024 SH03 Purchase of own shares.
04 Jun 2024 SH08 Change of share class name or designation
29 May 2024 SH01 Statement of capital following an allotment of shares on 30 April 2024
  • GBP 2,048.9416
22 Mar 2024 CH01 Director's details changed for Dr Christian Billy Jung on 22 March 2024
12 Jan 2024 SH08 Change of share class name or designation
13 Dec 2023 CS01 Confirmation statement made on 6 December 2023 with updates
06 Dec 2023 SH08 Change of share class name or designation
05 Dec 2023 SH06 Cancellation of shares. Statement of capital on 29 September 2023
  • GBP 2,034.9520
05 Dec 2023 SH06 Cancellation of shares. Statement of capital on 13 November 2023
  • GBP 2,033.9770
05 Dec 2023 SH03 Purchase of own shares.
04 Dec 2023 SH10 Particulars of variation of rights attached to shares
04 Dec 2023 SH10 Particulars of variation of rights attached to shares
20 Oct 2023 SH01 Statement of capital following an allotment of shares on 12 October 2023
  • GBP 2,045.2141
13 Oct 2023 TM01 Termination of appointment of Nicola Thompson as a director on 30 September 2023
18 Sep 2023 AA Accounts for a small company made up to 31 December 2022
23 Aug 2023 MR04 Satisfaction of charge 111199590001 in full
16 Aug 2023 MR01 Registration of charge 111199590002, created on 31 July 2023
04 Aug 2023 SH01 Statement of capital following an allotment of shares on 3 August 2023
  • GBP 1,995.2141
21 Jul 2023 SH01 Statement of capital following an allotment of shares on 21 July 2023
  • GBP 1,995.1849
30 Jun 2023 SH01 Statement of capital following an allotment of shares on 31 May 2023
  • GBP 1,994.2388
30 May 2023 PSC08 Notification of a person with significant control statement
30 May 2023 PSC07 Cessation of Advent Life Sciences Llp as a person with significant control on 12 December 2022
02 May 2023 SH01 Statement of capital following an allotment of shares on 30 April 2023
  • GBP 1,942.5908
20 Apr 2023 AP01 Appointment of Mr Bart Dzikowski as a director on 17 April 2023
20 Apr 2023 TM01 Termination of appointment of Florian Muellershausen as a director on 17 April 2023